Inventor
William L. Matier
Inventor
Libertyville, IL, US
Overview
Patents· 53 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
C07CAcyclic or carbocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07HSugars2%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
8,383,648'Amelioration of the development of cataracts and other ophthalmic diseases'20137,825,134'Amelioration of cataracts, macular degeneration and other ophthalmic diseases'20107,678,829'Oculoselective drugs and prodrugs'20107,589,107'Amelioration of vitrectomy-induced cataracts'20097,442,711'Amelioration of the development of cataracts and other ophthalmic diseases'20086,197,817'Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders'20015,536,749'Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents'19965,064,827'Polyhydroxybenzyloxpropanolamines'19915,059,620'Aryl substituted aminomethyl benzene derivatives'19914,990,668'Optically active aryloxypropanolamines and arylethanolamines'19914,966,914'Oculoselective beta-blockers as antiglaucoma agents'19904,959,390'Polyhydroxybenzyloxypropanolamines'19904,935,421'2-hydroxypropylamine aryl ester derivatives and pharmaceutical use'19904,923,873'Quinazoline substituted aminomethyl benzene derivatives'19904,906,661'Esters of aryloxypropanolamine derivatives'19904,897,417'Prodrugs of 3,4-hydroxy benzoyloxypropanolamines'19904,895,934'Process for the preparation of clindamycin phosphate'19904,849,515'Clindamycin-2-phosphoryl benzylate'19894,810,704'Substituted 2-amino-2-imidazolines as antifibrillatory agents'19894,810,717'2-hydroxypropylamine aryl ester derivatives'19894,810,714'Substituted 2-amino-2-imidazolines as antifibrillatory agents'19894,804,677'Esters of aryloxypropanolamine derivatives'19894,798,892'2-hydroxypropylamine heteroaryl ester derivatives'19894,778,807'Substituted 2-amino-2-imidazolines as antifibrillatory agents'19884,755,527'Aryl substituted aminomethyl benzene derivatives'19884,748,184'Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility'19884,692,446'Esters of aryloxypropanolamine derivatives and medicinal uses'19874,666,924'Certain pyridyl substituted aminomethyl benzene derivatives having anti-arrhythmic activity'19874,623,652'Esters of thiadiazole oxypropanolaine derivatives and pharmaceutical uses'19864,582,855'Aromatic and esters of hydroxypropylamines'19864,578,403'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19864,562,201'Aminomethyl benzanilides'19854,559,359'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19854,517,188'1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols'19854,508,725'Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives'19854,501,912'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19854,466,965'Phthalazine compounds, compositions and use'19844,455,317'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19844,454,154'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19844,402,974'Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents'19834,334,088'2-Alkynyl-5-indanyloxyacetic acids'19824,321,398'Thienyl and benzothienyl-tertiary butylaminophenoxypropanols'19824,291,168'Silylated indanyloxyacetates'19814,259,482'Thiadiazine compound'19814,247,715'2-Alkynyl-5-indanyloxyacetic acids'19814,243,681'Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof'19814,206,142'Styrylamidine process'19804,148,908'Indolyl cyanomethylphenethanolamines'19794,130,663'Styrylamidines'19784,096,183'Styrylsulfonylamidines'19784,060,615'2-Piperazinyl-6,7-dimethoxyquinazolines'19774,055,658'Cyanomethylphenethanolamines'19774,052,455'Styrylamidines'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977–1985Patents assigned to MEAD JOHNSON & CO (14)· patent assignee history
1977–1981Based in Evansville, IN, US· patent location history
1981–1991Based in Libertyville, IL, US· patent location history
1983–1986Patents assigned to AMERICAN HOSPITAL SUPPLY CORP (11)· patent assignee history
1983–1985Based in Liberty, IL, US· patent location history
1987–1991Patents assigned to DU PONT (19)· patent assignee history
1989–2013Based in Hockessin, DE, US· patent location history
1991Patents assigned to DU PONT MERCK PHARMA (2)· patent assignee history
2008–2010Patents assigned to OTHERA HOLDING INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DU PONT | 19 | 1987–1991 |
| MEAD JOHNSON & CO | 14 | 1977–1985 |
| AMERICAN HOSPITAL SUPPLY CORP | 11 | 1983–1986 |
| OTHERA HOLDING INC | 3 | 2008–2010 |
| DU PONT MERCK PHARMA | 2 | 1991 |
Locations
| Location | Patents | Span |
|---|---|---|
| Libertyville, Illinois, US | 28 | 1981–1991 |
| Hockessin, Delaware, US | 13 | 1989–2013 |
| Evansville, IN, US | 10 | 1977–1981 |
| Liberty, Illinois, US | 2 | 1983–1985 |